PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,293 | +175.0% | 3,269 | +259.2% | 0.02% | +100.0% |
| Q2 2023 | $36,464 | +26.6% | 910 | +28.9% | 0.01% | +22.2% |
| Q1 2023 | $28,812 | +22.9% | 706 | +16.3% | 0.01% | +12.5% |
| Q4 2022 | $23,436 | -82.8% | 607 | -76.2% | 0.01% | -88.1% |
| Q3 2022 | $136,000 | +20.4% | 2,547 | +31.6% | 0.07% | -4.3% |
| Q2 2022 | $113,000 | -38.6% | 1,935 | -19.7% | 0.07% | -23.9% |
| Q1 2022 | $184,000 | +32.4% | 2,411 | +4.3% | 0.09% | +41.5% |
| Q4 2021 | $139,000 | +17.8% | 2,312 | +9.9% | 0.06% | -14.5% |
| Q3 2021 | $118,000 | +12.4% | 2,103 | +21.8% | 0.08% | +15.2% |
| Q2 2021 | $105,000 | – | 1,727 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |